19 research outputs found
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study
(Peg)interferon ((Peg)IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand
Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs
Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.
<p>Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.</p
Hemoglobin decline at week 4 of therapy and management of anemia stratified by ITPA deficiency.
<p>*No ITPA deficiency vs any ITPA deficiency.</p
A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals
Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).
<p>Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).</p
Correlation between HBV core-related antigen and the new quantitative IGG anti-core in treated caucasian HBeAg-negative patients and inactive carriers with and without a functional cure
Quantitative detection of total and defective HCV RNA in a subset of patients who carried defective HCV forms.
<p>Quantitative detection of total and defective HCV RNA in a subset of patients who carried defective HCV forms.</p